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In 2004, the International Agency for Research on Cancer (IARC) reclassified formaldehyde (FA) from a probable
(Group 2A) to a known human carcinogen (Group 1) citing results for nasopharyngeal cancer (NPC) mortality from
the follow-up through 1994 of the National Cancer Institute formaldehyde cohort study. To the contrary, in 2012,
the Committee for Risk Assessment of the European Chemicals Agency disagreed with the proposal to classify FA
as a known human carcinogen (Carc. 1A), proposing a lower but still protective category, namely as a substance
which is presumed to have carcinogenic potential for humans (Carc. 1B). Thus, U.S. and European regulatory
agencies currently disagree about the potential human carcinogenicity of FA.
In 2013, the National Cancer Institute reported results from their follow-up through 2004 of the formaldehyde
cohort and concluded that the results continue to suggest a link between FA exposure and NPC. We discuss in
this commentary why we believe that this interpretation is neither consistent with the available data from the most
recent update of the National Cancer Institute cohort study nor with other research findings from that cohort, other
large cohort studies and the series of publications by some of the current authors, including an independent study
of one of the National Cancer Institute’s study plants.
Another serious concern relates to the incorrectness of the data from the follow-up through 1994 of the National
Cancer Institute study stemming from incomplete mortality ascertainment. While these data were corrected by
the National Cancer Institute in subsequent supplemental publications, incorrect data from the original publications
have been cited extensively in recent causal evaluations of FA, including IARC. We conclude that the NCI
publications that contain incorrect data from the incomplete 1994 mortality follow-up should be retracted entirely
or corrected via published errata in the corresponding journals, and efforts should be made to re-analyze data from
the 2004 follow-up of the NCI cohort study.
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In 2004, the International Agency for Research on Cancer
(IARC) reclassified formaldehyde (FA) from a probable
(Group 2A) [1] to a known human carcinogen (Group 1)
[2] citing the National Cancer Institute (NCI) cohort ana-
lyses for nasopharyngeal cancer mortality (NPC) [3]. Based
on the same NCI findings, the Group 1 classification was* Correspondence: gmarsh@pitt.edu
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unless otherwise stated.upheld by IARC following the working group meeting for
IARC Monograph Volume 100 F [4]. In Europe, the NCI
FA cohort study as published by Hauptmann et al. [3] and
evaluated by IARC 2006 [2] was also debated in detail to
justify an appropriate cancer classification for FA according
to the EU rules. The Committee for Risk Assessment of
the European Chemicals Agency (RAC) disagreed with the
proposal to classify FA as a known human carcinogen
(Carc. 1A), proposing a lower but still protective category,
namely as a substance which is presumed to have carcino-
genic potential for humans (Carc. 1B). In 2011, in the US,
the National Toxicology Program classified FA as a “knowntd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ings of the NCI study [5].
The French Agency for Food, Environmental and Oc-
cupational Health & Safety (ANSES)a, on behalf of the
French Ministries of Health, the Environment and Labor,
prepared a proposal for harmonized classification and
labeling of FAb after IARC’s decision to classify as a
human carcinogen. The responsible Committee for Risk
Assessment (RAC)c of the European Chemicals Agencyd
evaluated this proposal in 2012. The major discussion
issue at RAC was the correct interpretation of the NCI
FA cohort study on NPC mortality [3] taking into ac-
count all peer-reviewed publications that referred to this
study and that explored the issue of NPC risk after FA
exposure, in particular those publications that were pub-
lished after 2004.
The Committee for Risk Assessment disagreed with
the proposal to classify FA as known to have carcino-
genic potential to humans (Carc. 1A), proposing a lower
but still protective category, namely as a substance
which is presumed to have carcinogenic potential for
humans (Carc. 1B)e. Thus, U.S. and European regulatory
agencies currently disagree about the potential human
carcinogenicity of FA. Despite the fact that the classifica-
tion systems of the different agencies are not identical
the main message is clear: The RAC did not follow
IARC's evaluation on human carcinogenicity.The National Cancer Institute formaldehyde cohort study
In June 2013, the NCI published the findings of its update
through 2004 of mortality from solid tumors among
workers in the US industry-wide FA study [6]. This study
includes 10 plants and represents the largest cohort study
of workers with potential exposure to FA [7]. The purpose
of the Beane Freeman et al. update [6] was to extend the
mortality follow-up through 2004 and to examine the as-
sociations among different exposure characterizations and
mortality from several solid tumors. This study also in-
cluded corrections to the earlier update of mortality
through 1994 published in 2004 by Hauptmann et al.
[8]. Beane Freeman et al. [6] claim that a persistent in-
creased risk remains for NPC mortality associated with
peak, average intensity and cumulative FA exposure
metrics as reported in Hauptmann et al. [3], although
this NPC risk was not reported by Blair et al. [7] in the
original FA cohort analysis based on follow-up through
1979. The main conclusion from Beane Freeman et al.
[6] is that the update through 2004 suggests a link be-
tween FA exposure and NPC mortality that is consistent
with some case–control studies [9-14]. Aside from not
statistically significantly elevated rate ratios for salivary
gland cancer mortality, the authors observed no associa-
tions with mortality from other cancer types reported inother studies, including lung, laryngeal, nasal sinus and
brain [1,4].
The NCI FA cohort study has a number of strengths
including size, long follow-up time, several individual
worker-level FA exposure metrics, partial adjustment for
potential confounding factors, and the use of external
and internal comparison populations. However, we have
several concerns regarding the interpretation of the epi-
demiological findings from this study by Beane Freeman
et al. [6], in particular, the purported link between FA
exposure and NPC mortality. We believe that this inter-
pretation is neither consistent with the available data
nor with other research findings based on this group of
US formaldehyde workers. The series of publications by
the current authors and others present evidence [15-19].
Another serious concern relates to the incorrectness of
the data reported by Hauptmann et al. [3,20] stemming
from incomplete mortality follow-up that was first re-
ported by Beane Freeman et al. [21]. While these data
were corrected in subsequent supplemental publications
[8,22], incorrect data from the original publications by
Hauptmann et al. have been cited extensively in recent
causal evaluations of FA, including IARC [4]. We note
that IARC’s evaluation in 2004 [2] was mainly based on
Hauptmann et al. [3,20].
This commentary describes our concerns and provides
justification for continued re-analysis of the NCI cohort
data on mortality. We will refer to three specific publica-
tions from updates of the NCI FA cohort: namely, the
1994 mortality update [3], corrections to the 1994 mor-
tality update published as supplementary data [8,22] and
the 2004 mortality update [6].
Issue 1 – Inconsistently reported cohort data
In 2010, Marsh et al. [15] described several major discrep-
ancies between the number of observed deaths reported
by Hauptmann et al. [3] and Beane Freeman et al. [22]. A
main finding was that the corrected increase for total
deaths by FA exposure status apparently equals 995, not
1006 as described by Beane Freeman [21]. We also found
that when exposure is defined using a 2-year lag (used in
the NCI analysis of lympho-hematopoietic cancers [3]),
the percent increase in corrected numbers of deaths
among FA “unexposed” subjects is approximately two
times greater than that observed among FA “exposed”
subjects for all deaths, all cancer deaths and all solid can-
cers [15]. Moreover, the basis of NCI’s revised count of
1006 deaths is neither evident nor reproducible from in-
formation provided. The most recent NCI publication
by Beane Freeman et al. [6,8] did not clarify the discrep-
ancy. Beane Freeman et al. [6] state (page 1016) that
Hauptmann et al. [3] had missed 999 deaths and had
counted four living subjects as deceased. They also re-
ported 20 subjects whose age had exceeded the age of
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information suggests that the corrected total death
count should be 1015 (999-4 + 20), not the 1006 re-
ported by Beane Freeman et al. [6]. Inconsistent with
both numbers (1015 and 1006) that can be derived from
Beane Freeman et al. [6], Table S1 in Beane Freeman
et al. [8] yields a difference of 995 in comparison to
Table two in Hauptmann et al. [3]. The identified differ-
ences are small and may have no substantial effect on
estimates of relative risks, but the discrepancies between
the original and corrected total numbers of deaths in
the NCI cohort creates doubt whether all ascertainment
errors were addressed by the NCI, as the consistent
differential change in cause-specific numbers of deaths
by exposure category cannot likely be explained as a
chance occurrence. At the time of this publication, the
NCI investigators have not presented an explicit clarifi-
cation of the mortality ascertainment errors and the
changes in total deaths and cause-specific deaths from
the reported numbers presented in the Hauptmann
et al. publications.
Issue 2 – Relevance of NCI’s corrected number of deaths
Tables 1, 2, 3 summarize key results from Hauptmann
et al. [3], the only published corrections to this publica-
tion [8], and the updated mortality results reported by
Beane Freeman et al. [6] for all causes of death com-
bined and for NPC mortality in relation to FA exposure
status based on external and internal comparisons. The
inclusion of the claimed 1006 deaths missing in the ana-
lyses by Hauptmann et al. [3] had a major impact on the
corrected risk estimates for total mortality, especially
those based on internal cohort comparisons (Table 2).
For example, excesses in total mortality ranging from 7%Table 1 Standardized mortality ratios and numbers of deaths
statuse
NCI update
Non-exposed
No. deaths SMR
All causes of death
NCI 1994 updatea. 1,991 0.85*
NCI 1994 update (corrected)b. 2,169 0.89*
NCI 2004 updatec. 2,605 0.90*
NPC deaths (IC
NCI 1994 updatea. 2 1.56
NCI 1994 update (corrected)b. 2 1.57
NCI 2004 updatec. 2 1.45
a.Hauptmann et al. [3].
b.Beane-Freeman et al. [8].
c.Beane-Freeman et al. [6].
d.95% confidence intervals based on exact methods.
e.FA exposure status calculated using 15-year time lag.
*95% CI does not include 1.00.to 21% among workers in the two highest categories of
ever-peak FA exposure (2 – 4 ppm and > 4 ppm) attenu-
ated to deficits ranging from 4% to 15% in analyses that
corrected the Hauptmann et al. publication [8] or updated
the mortality follow-up [6], including some reduced risk
estimates that were statistically significant. The overall
standard mortality ratios (SMRs) were relatively unaffected
by the corrections but corrected results for the 1994 mor-
tality follow-up were more consistent with those reported
in the most recent 2004 follow-up (Table 1). Thus, to clar-
ify the record on the impact of these corrections, we sub-
mit that the incorrect NCI publications [3,20] should be
retracted entirely or corrected via published errata in the
corresponding journals.
Issue 3 – New NCI findings for NPC argue against an
association with FA exposure
Beane Freeman et al. [6] reported results for updated
mortality ascertainment through 2004 that provide evi-
dence against an association between FA and NPC mor-
tality. First, the most recent 10-year period of follow-up
of the NCI FA cohort yielded only one additional NPC
death. Further, this single NPC death occurred in the
lowest exposure categories for the three FA exposure
metrics evaluated by Beane Freeman et al. (Table 3). The
observation of only one NPC death during a 10-year up-
date of this large cohort is less than the corresponding
number of expected NPC deaths for this period (1.14 as
derived from information provided in the supplemental
tables and the published report by Beane Freeman et al.
[6,8]). First, this result by itself, argues against an associ-
ation between FA exposure and NPC mortality. Second,
unlike results reported in Hauptmann et al. [3] and the
corrected analyses for the update through 1994 [8], thefor all causes combined by NCI update and FA exposure
Formaldehyde exposure status
Exposed
95% CI No. deaths SMR 95% CI
(ICD8: 001-999)
0.81-0.89 6,495 0.96* 0.94-0.98
0.86-0.93 7,312 1.02 0.99-1.04
0.87-0.94 11,346 1.03* 1.01-1.05
D8: 147)d.
0.39-6.23 8 2.10 0.91-4.14
0.40-6.28 8 2.13 0.92-4.19
0.17-5.25 9 1.84 0.84-3.49
Table 2 Rate ratios and numbers of deaths for all causes combined by NCI update and peak FA exposuref
NCI update
Peak exposure (ppm)
p-value
trendd.
p-value
trende.
0 >0 - < 2.0 2.0 - < 4.0 ≥ 4.0
RR 95% CI No.deaths RR 95% CI
No.
deaths RR 95% CI
No.
deaths RR 95% CI
No.
deaths
NCI 1994 updatea. 1.05 1,991 1.00 Baseline 2,554 1.21* 1,945 1.07* 1,996 0.013 0.014
NCI 1994 update
(corrected)b.
1.02 0.85-1.04 2,169 1.00 Baseline 3,201 0.96 0.91-1.02 2,012 0.86* 0.81-0.91 2,099 <0.001 <0.001
NCI 2004 updatec. 0.98 0.93-1.04 2,605 1.00 Baseline 4,996 0.95* 0.90-0.99 3,096 0.85* 0.81-0.89 3,254 <0.001 <0.001
a.Hauptmann et al. [20].
b.Beane-Freeman et al. [8].
c.Beane-Freeman et al. [6].
d.Two-sided likelihood ratio test (1df) of zero slope for continuous formaldehyde exposure among exposed person-years only.
e.Two-sided likelihood ratio test (1df) of zero slope for continuous formaldehyde exposure among unexposed and exposed person-years.
f.FA exposure metric calculated using 15-year time lag.
*95% CI does not include 1.00.
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the most recent update through 2004 [6] is no longer
greater than 2.00 and is not statistically significant
(SMR = 1.84, 95% CI = 0.84-3.49) (Table 1). Third, the
SMR for NPC among FA-exposed workers is now con-
sistent with the corresponding SMR for all workers
unexposed to FA (SMR = 1.45, 95% CI = 0.17-5.25), as
the 95% confidence interval for FA-exposed workers isTable 3 Rate ratios and numbers of deaths for NPC by NCI up
NCI update RR 95% CI No.
deaths
RR 95% CI No.
deaths
R
Peak exposu
0 > 0 - < 2.0
NCI 1994 updatea. 1.00 Baseline 2 NA 0
NCI 1994 update
(corrected)b.
1.00 Baseline 2 NA 0
NCI 2004 updatec. 4.39 0.36-54.05 2 1.00 Baseline 1
Average intensity of
0 0.1-0.4
NCI 1994 updatea. 1.00 Baseline 2 NA 0
NCI 1994 update
(corrected)b.
1.00 Baseline 2 NA 0 0.3
NCI 2004 updatec. 6.79 0.55-83.64 2 1.00 Baseline 1 2.4
Cumulative exposu
0 > 0 - < 1.5
NCI 1994 updatea. 2.40 2 1.00 Baseline 3
NCI 1994 update
(corrected)b.
2.41 0.35-16.70 2 1.00 Baseline 3 1.2
NCI 2004 updatec. 1.87 0.30-11.67 2 1.00 Baseline 4 0.8
a.Hauptmann et al. [3].
b.Beane-Freeman et al. [8].
c.Beane-Freeman et al. [6].
d.Two-sided likelihood ratio test (1df) of zero slope for continuous formaldehyde ex
e.Two-sided likelihood ratio test (1df) of zero slope for continuous formaldehyde ex
f.All FA exposure metrics calculated using 15-year time lag.
*95% CI does not include 1.00.entirely contained within the confidence interval for
FA-unexposed workers (Table 1).
Table 3 also shows that for the ever-peak exposure
metric, the rate ratio (RR) for the two NPC deaths in the
unexposed category compared with the single NPC death
in the lowest exposed category is now 4.39 (95% CI = 0.36-
54.05). This result is consistent with the RR for the highest
category of ever-peak exposure (RR = 7.66, 95% CI = 0.94-date and FA exposure metricf
R 95% CI No.
deaths
RR 95% CI No.
deaths
p-value
trendd.
p-value
trende.
re (ppm)
2.0 - < 4.0 4.0
NA 0 1.83 7 0.044 <0.001
NA 0 1.82 0.32-10.46 7 <0.001 0.05
NA 0 7.66 0.94-62.34 7 0.005 0.10
exposure (ppm)
0.5-0.9 ≥ 1.0
1.38 1 1.67 6 0.126 0.066
7 0.03-4.63 1 1.66 0.29-9.48 6 0.07 0.14
4 0.15-39.07 1 11.54* 1.38-96.81 6 0.09 0.16
re (ppm-years)
1.5 - < 5.5 ≥ 5.5
1.19 1 4.14 3 0.029 0.025
0 0.12-11.56 1 4.15 0.83-20.78 3 0.04 0.05
6 0.10-7.70 1 2.94 0.65-13.28 3 0.06 0.07
posure among exposed person-years only.
posure among unexposed and exposed person-years.
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overlap (heterogeneity chi-squared = 0.07 (d.f. = 1), p =
0.79). Likewise, RRs for the unexposed categories of
average intensity and cumulative exposures (compared
with the lowest exposure category for both metrics as the
referent) were also elevated (RR = 6.79, 95% CI = 0.55-
83.64 and RR = 1.87, 95% CI = 0.30-11.67, respectively).
Finally, for average intensity and cumulative exposures,
RRs for the moderate exposure categories (compared with
the lowest exposure categories for both metrics) are now
less than the RRs for the unexposed category (RR = 2.44,
95% CI = 0.15-39.07 and RR = 0.86, 95% CI = 0.10-7.70,
respectively). These reported findings by Beane Freeman
et al. [6] indicate that there is no meaningful difference in
the RRs for NPC mortality between the unexposed and
FA-exposed groups.
Compared with the original and corrected 1994 mor-
tality updates [3,8], the 2004 mortality update reported
by Beane Freeman et al. [6] provides little or no evidence
of an exposure-response relationship for FA exposure and
NPC mortality as shown in Table 3. First, the reported
RRs are difficult to compare to RRs reported earlier due to
the substantial methodological change of using the lowest
exposure category as the reference rather than the use of
the unexposed category as the reference in the previous
1994 update (discussed below under Issue 4). Second, for
the same reason, the claim by Beane Freeman et al. [6]
that a statistically significant trend (p = 0.005) for RRs for
the ever-peak exposure analyses as based on FA-exposed
workers only is difficult to compare to earlier findings (as
discussed under Issue 5). Third, none of the trend tests in-
corporating all exposure categories in Beane Freeman
et al. [6] are statistically significant. As noted by Beane
Freeman et al. [6] (page 1018), “RRs calculated using non-
exposed as the referent were attenuated, which is also
reflected in the tests for trend using all person-years…”.
This is evident in the results summarized in Table 3 that
p-values for all trend tests estimated based on all unex-
posed and exposed person years are greater than 0.05.
These results suggest that the mortality excesses for NPC
among subjects unexposed to FA are simply due to chance
or reflect the presence of some other exogenous factor
outside of the study plants, consistent with findings re-
ported by Marsh et al. [16] for Plant 1 (discussed below
under Issue 7).
Issue 4 – Inappropriateness of excluding unexposed workers
from the evaluation of exposure-response relationships
As noted throughout this commentary, Beane Freeman
et al. [6] fails to address statistical evidence that non-
exposure to FA is also associated with NPC mortality.
The language used by Beane Freeman and colleagues in
the published abstract states that previously observed ex-
cesses of NPC mortality “persisted” in the 2004 mortalityupdate. This term implies that updated analyses were con-
sistent with the previous reports and resulted in similar
risk estimates for the three exposure metrics: peak, aver-
age intensity, and cumulative exposure as reported by
Hauptmann et al. [3]. This interpretation is not accurate.
In fact, the addition of one NPC death during the recent
10 years of additional follow-up changed the analytic ap-
proach for calculating RRs for both peak and average in-
tensity exposures (Table 3). That is, the additional death
was assigned to the "low" exposure group for each metric
(0–2 ppm for ever-peak, and 0.1 - 0.4 ppm for average
intensity exposure). In the previous mortality update
through 1994 [3], and correction to this publication re-
ported by Beane Freeman et al. [8], these "low" categor-
ies had zero observed NPC deaths, thus the "unexposed"
category was used as the referent for internal RR analyses.
Therefore, the estimates reported by Beane Freeman et al.
[6] do not represent a "persistent" excess risk for ever-
peak and average intensity exposures as they are relative
to different referent categories for each exposure metric
and must be interpreted in the context of the specified ref-
erent category.
It is inappropriate to exclude unexposed workers from
internal analyses as done by Beane Freeman et al. [6].
All workers are from the same factories and, as noted
by McLaughlin et al. [17] in a response to a letter by
Hauptmann and Ronckers [23], lagging of FA exposure
by 15 years results in contributions to the unexposed
category from workers who were, in fact, exposed to FA.
In fact, most of the person-time at risk allocated to the un-
exposed category represents years of follow-up of workers
who were eventually exposed to FA. Thus, even speculated
differences between unexposed and exposed workers with
regard to unknown confounders cannot be used to justify
the choice of the low-FA exposure category rather than the
non-exposed category as the reference category for the cal-
culation of relative risks [17].
Issue 5 - The trend tests used in the NCI 2004 updates
produce misleading results and may be mis-specified
Beane Freeman et al. [6] used trend tests for categorical
variables based on the likelihood ratio for the slope of
the corresponding continuous variable, except for peak
exposure, which was based only on categorical scores.
Beane Freeman and colleagues provide no slope param-
eter estimates from the Poisson regression analysis of the
continuous exposure values, and no indication that the
authors evaluated the underlying assumptions and fit of
the model. Assuming that the underlying assumption of
linearity was met, Beane Freeman et al. could have used
the slope parameter estimates to determine the increase in
the RR per unit increase of FA exposure. In addition,
Beane Freeman et al. placed the continuous variable-based
trend test p-values in juxtaposition to the RRs derived
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ingly inconsistent results. For example, as shown in Table 3
the pattern of RRs across the four cumulative exposure
categories are 1.87, 1.0 (baseline), 0.86 and 2.94. As shown
in Figure 1, with or without the inclusion of the unex-
posed, these data provide no evidence on an increasing
linear trend in RRs relative to increasing cumulative ex-
posure to FA, yet trend test p-values are reported as 0.06
and 0.07 [6] without and with the unexposed category, re-
spectively. Also, given that these p-values are 2-sided and
a large number of person-years were accrued in the FA-
unexposed category, it is also possible that these p-values
indicate a nearly statistically significant inverse trend.
It is also quite possible that the inconsistent pattern of
findings between the continuous and categorical data
reflects the presence of an underlying non-linear relation-
ship between log RR and continuous exposure. For ex-
ample, if the underlying log RR vs. continuous exposure
relationship was quadratic, the continuous model includ-
ing the unexposed subjects could yield a marginally statis-
tically significant positive slope in conjunction with no
apparent trend or a U-shaped relationship in the RRs
across the four exposure categories. An informative
Poisson regression modeling approach would present an
evaluation of the linearity assumption of the continuous
model (i.e., linearity of log RR vs. continuous exposure),
and if linearity is met, the corresponding slope estimates
and confidence intervals.
In addition to the continuous model estimates for the
continuous exposure variables, Beane Freeman et al. [6]
should show trend tests based on the midpoints (or0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Unexposed >0 - <1.5
R
at
e 
R
at
io
  
Cumulative FA
Trend p-value = 0
Trend p-value = 0.07 (u
(based on continuous fo
Figure 1 Rate ratios and 95% confidence intervals for NPC by cumulascores) of the categorical data presented in the tables. This
categorization of the continuous variable is arbitrary, and
the concurrent trend tests based on categorical midpoints
(which also require underlying linearity with respect to log
RR vs. midpoint score) directly reflect the reported and
apparent pattern of categorical RRs presented in the ta-
bles. This avoids possible misrepresentation or confusion
about trends (or lack thereof) based on the underlying
and unseen continuous data. Non-linearity in the continu-
ous log RR vs. continuous FA exposure relationship, such
as a quadratic relationship, would invalidate the current
trend tests. Another problem with the trend tests reported
by Beane Freeman et al. [6] is the instability of the RR esti-
mates based on only one observed death that occur in
some baseline categories of the reported trends. This is es-
pecially problematic for the categorical analysis of NPC
highest peak exposure (Table 3).
Issue 6 – Failure to recognize the important interaction
structure between plant group and FA exposure
In regard to analyses reported by Marsh et al. [18], Beane
Freeman et al. [6] state in the discussion section (page
1023), “Based on two groups of plants (plant 1 vs. plants
2–10) and a continuous version of the originally categorical
peak metric they demonstrated no significant interaction
between plant group and peak exposure (p = 0.09) and ad-
justment for plant group did not markedly change the risk
related to peak exposure”. Beane Freeman et al. [6] further
state, “These results are consistent with our own analyses
that showed no evidence of plant heterogeneity for a broad
group of metrics, including peak exposure.” First, the so-1.5 - <5.5 5.5+
 Exposure (ppm-years)
.06 (exposed only)
nexposed and exposed)
rm of FA exposure data)
tive exposure (lagged 15 years) to FA (Beane Freeman et al. [6]).
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and colleagues, amounts to excluding each of the 10 study
plants one at a time to evaluate the consistency of the
findings (a type of sensitivity analysis). This influence ana-
lysis was new to the 2004 mortality update [6] and pre-
sumably an attempt to address the heterogeneity in results
for NPC by plant reported in the reanalyses of Marsh and
Youk [19] and Marsh et al. [18]. Although Beane Freeman
and colleagues address plant heterogeneity systematically,
the authors neither correctly interpret the results of this
analysis nor correctly interpret the results of the inter-
action evaluation performed by Marsh et al. [18].
Regarding the results of the reported influence analysis
in the publication, Beane Freeman et al. [6] conclude
that there is an apparent absence of plant heterogeneity
upon removing Plant 1. However, the RR for NPC mortal-
ity in the highest category of ever-peak exposure de-
creased 56% from 7.66 for the 7 deaths including Plant 1,
(95% CI = 0.94-62.34) to 3.36 for 2 deaths excluding Plant
1, (95% CI = 0.30-37.27). Moreover, the corresponding RR
for the highest average intensity category of FA exposure
decreased 65% from 11.54 for 6 deaths including Plant 1
(95% CI = 1.38-96.81) to 4.09 for 1 death excluding Plant
1, (95% CI = 0.25-66.0). These results for the influence
analysis are quite similar to the RR for unexposed workers
(RR = 4.39, 95% CI = 0.36-54.05). Further, when Plant 1
was included in the analysis and any other plant (from
Plant 2 through Plant 10) was excluded, the results were
similar to the results for analyses reported for all 10 plants.
This pattern of findings in Beane Freeman et al. [6] is en-
tirely consistent with the results of Marsh and Youk [19]
which showed that the conclusion of a causal association
was driven heavily by the large, statistically significant ex-
cess in NPC mortality risk for employees from Plant 1 for
the highest ever-peak exposure category.
Regarding the interpretation by Beane Freeman et al.
[6] of the results of the Marsh et al. [18] interaction
evaluation, it is not true as stated by Beane Freeman and
colleagues (page 1023) that the Marsh et al. analysis does
not demonstrate a significant interaction between plant
group and peak exposure. Rather, Marsh et al. [18] found
that after dropping the main effect of plant group from the
full interaction model (Model 9) the estimation process
yielded more stable findings (Model 8) and the interaction
between the plant group indicator and continuous peak
exposure was found to be significant (p = 0.03). Unfor-
tunately, a rigorous interaction analysis, such as that
recommended and conducted by Marsh et al. [18] was
not performed by Beane Freeman and colleagues.
Issue 7 – Misrepresented findings from the independent
study of Plant 1
In 2007, Marsh et al. [16] reported findings from a 2003
update of their independent and expanded study of Plant1 designed to investigate alternative explanations for the
anomalous findings for NPC in this single plant. The re-
sults of the nested case–control study suggested that the
large NPC mortality excess in Plant 1 may not be due to
FA exposure, but rather reflects the influence of external
employment in the ferrous and non-ferrous metal indus-
tries of the local area that entailed possible exposures to
several suspected risk factors for upper respiratory system
cancer (e.g., sulfuric acid mists, mineral acid, metal dusts
and heat) [16].
In response to these findings, Beane Freeman [6] state
(page 1022), “Silversmithing was associated with risk of
NPC, and Marsh et al. [16] concluded that the observed
association between FA and NPC may actually be due to
silversmithing. However, risks related to duration, cumu-
lative and average intensity of exposure did not decrease
when smoking and silversmithing or other metal work
were added as adjustment variables, indicating that sil-
versmithing does not confound the association between
FA and NPC”. We disagree with this interpretation be-
cause it assumes the presence of an association between
FA and NPC that was not evident in the Marsh et al. Plant
1 study. In fact, Marsh et al. [16] observed considerable
evidence that the overall NPC excess was not related to
FA exposure in Plant 1. This additional evidence, sum-
marized below, was not considered by Beane Freeman
and colleagues in their discussion of the Marsh et al.
Plant 1 study.
First, large, statistically significant NPC excesses were
observed in both short-term (less than one year) and
long-term workers (SMR = 5.35 and 4.59, respectively).
Second, the seven NPC cases were associated with very
short periods of Plant 1 employment (4 of 7 NPC cases
worked less than one year, 5 of 7 cases worked less
than five years), with low average intensity of FA ex-
posure (the range of exposures for the 7 cases was
0.03-0.60 ppm with median of 0.14 ppm). Moreover,
the NPC cases were concentrated among workers hired
at Plant 1 during 1947–56, which was not the time
period of highest FA exposure. Third, for average in-
tensity of exposure, the metric most closely associated
with the highest peak metric used in the NCI study,
there was no evidence of an increasing NPC risk with
increasing exposure (OR = 1.00, 11.41 and 2.18 for the
categories <0.03 ppm (baseline), 0.03-0.159 ppm, and
0.16+ ppm, respectively). Finally, Beane Freeman et al.
[6], observed mostly null findings for respiratory cancer
sites other than NPC, in contrast to elevations in risk
for these sites in the Marsh et al., Plant 1 study. For ex-
ample, with the exceptions of cancer of the tongue and
gum, local county rate-based SMRs in the Marsh et al.
study were elevated for all upper respiratory cancer sites,
including the nasal sinuses that do not seem to be pene-
trated by FA exposures [24].
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increased risk of NPC
As noted by McLaughlin and Tarone in a commentary
[25] and recent letter to the editor and response [26,27],
Beane Freeman et al. [6] cite the NCI embalmer case–
control study [28] in their discussion as evidence for a
possible leukemia risk among FA-exposed workers, but ig-
nore the absence of increased risk of NPC in the em-
balmer study. The odds ratio for NPC among embalmers
was 0.10 (95% CI = 0.01-1.20), despite the fact that em-
balmers were reported to have the highest peak exposure
to FA of any known occupation [28]. Also, the recent up-
date of the NIOSH garment industry worker cohort [29]
was not mentioned by Beane Freeman et al. [6] but only
the older publication [30]. Interestingly, Meyers and
colleagues still found no NPC deaths although follow-
up of this FA exposed cohort was extended by 10 years
to 2008 (number of expected deaths = 1.33). Finally, the
most recent update of the British industry-wide FA
study also found fewer NPC deaths than expected (1 death
versus 2.0 expected) [31].
Conclusions
The interpretation of an association between FA expos-
ure and NPC mortality is neither consistent with the
available data from the most recent mortality update of
the FA cohort nor with other research findings from this
cohort, other large cohort studies [29-31] and the series
of publications by the current authors. The NCI publica-
tions [3,20] that contain incorrect data from the incom-
plete 1994 mortality follow-up should be retracted entirely
or corrected via published errata in the corresponding
journals. Efforts are underway by two of us (GM and PM)
to re-analyze the cohort data from NCI’s 2004 follow-up
with focus on a rigorous evaluation of the relationship be-
tween FA and NPC.
Endnotes
ahttp://www.anses.fr
bBased on Regulation (EC) No 1272/2008 (CLP Regu-
lation), Annex VI, Part 2
chttp://echa.europa.eu/about-us/who-we-are/committee-
for-risk-assessment
dECHA, http://echa.europa.eu
ehttp://echa.europa.eu/web/guest/view-article/-/journal_
content/c89bdb13-09e9-497c-8e73-ddae13a842c8)
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